NCT05155228

Brief Summary

This study evaluates the effectiveness of the Attachment Regulation and Competency (ARC) treatment framework in comparison to treatment as usual for reducing symptoms of PTSD and Developmental Trauma Disorder among children ages 8 to 16 with a history of exposure to multiple traumatic events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 24, 2017

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
9 months until next milestone

First Posted

Study publicly available on registry

December 13, 2021

Completed
Last Updated

December 13, 2021

Status Verified

November 1, 2021

Enrollment Period

4.6 years

First QC Date

March 24, 2017

Last Update Submit

November 30, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in baseline symptoms of PTSD at up to 24 weeks of treatment and 6-month follow up per the Clinician Administered PTSD Scale for Children and Adolescents, DSM 5 (CAPS-CA-DSM5)

    The Clinician Administered PTSD Scale for Children and Adolescents, DSM 5 (CAPS-CA-DSM5) is a clinical research interview assessing the severity and frequency of DSM 5 symptoms of posttraumatic stress disorder over the previous month. The CAPS yields a total severity score based on assessment of 20 symptoms of PTSD that can range from 0 to 80, with higher scores indicating a greater severity of PTSD symptoms.

    Change from baseline PTSD symptom severity at up to 24 weeks of treatment and 6-month follow up.

  • Change in baseline symptoms of Developmental Trauma Disorder (DTD) at up to 24 weeks of treatment and 6-month follow up

    The Developmental Trauma Disorder Structured Interview (DTD-SI) is a clinician-administered semi-structured diagnostic interview designed for a parent or other primary caregiver of a child 8 to 17 years old to describe problems the child has in three categories of dysregulation: (1) Affective and Physiological, (2) Attentional and Behavioral, (3) Self and Relational. Questions and interviewer ratings parallel those of the K-SADS. The DTD-SI yields a total symptom score ranging from 0 to 25, with higher scores indicating greater severity of DTD symptoms.

    Change from baseline DTD symptom severity at up to 24 weeks of treatment and 6-month follow up.

Secondary Outcomes (5)

  • UCLA Posttraumatic Stress Disorder -Reaction Index for DSM 5 (PTSD-RI-5)

    Change from baseline PTSD symptom severity at up to 12-weeks of treatment, up to 24 weeks of treatment and 6-month follow up.

  • Child Behavior Checklist (CBCL)

    Change from baseline in internalizing and externalizing problems at up to 12 weeks of treatment, up to 24 weeks of treatment, and 6-month follow up.

  • Behavior Rating Inventory of Executive Function - Parent Report (BRIEF-PR)

    Change from baseline in executive dysfunction at up to 12 weeks of treatment, up to 24 weeks of treatment and 6-month follow up.

  • Trauma Symptom Checklist for Children (TSCC)

    Change from baseline in symptoms of dissociation at up to 12 weeks of treatment, up to 24 weeks of treatment, and 6-month follow up.

  • NIH Toolbox for the Assessment of Neurological and Behavioral Function, Cognition Domain

    Change from baseline in executive function at up to 12 weeks of treatment, up to 24 weeks of treatment and 6-month follow up.

Other Outcomes (3)

  • Behavioral and Emotional Rating Scale, Second Edition (BERS-2)

    Change from baseline in resilience at up to 12 weeks of treatment, up to 24 weeks of treatment and 6-month follow up.

  • Emotion Regulation Checklist (ERC)

    Change from baseline in emotion regulation at up to 12 weeks of treatment, up to 24 weeks of treatment and 6-month follow up.

  • Brief Symptom Inventory (BSI)

    Change from baseline in caregiver mental health symptoms at up to 12 weeks of treatment, up to 24 weeks of treatment and 6-month follow up.

Study Arms (2)

Attachment Regulation and Competency

EXPERIMENTAL

Weekly individual psychotherapy for 24 weeks using the Attachment Regulation and Competency intervention.

Behavioral: Attachment Regulation and Competency

Treatment as usual

ACTIVE COMPARATOR

Weekly individual psychotherapy for 24 weeks.

Behavioral: Treatment as usual

Interventions

Trauma informed psychotherapy intervention for children with a history of exposure to trauma and their caregivers.

Attachment Regulation and Competency

Supportive psychotherapy

Treatment as usual

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • DTD diagnosis as measured by the DTD interview (using standard scoring criteria) or partial PTSD diagnosis as measured by the CAPS.
  • A history of at least two forms of trauma, at least one of which must be interpersonal in nature (sexual, physical or psychological maltreatment, neglect, abandonment or impaired caregiving) as indicated on the Trauma History Profile (THP).

You may not qualify if:

  • Serious illness that is not stabilized.
  • GAF \< 40.
  • Past diagnosis of autism spectrum disorder, mental retardation, or schizophrenia.
  • Current psychotic disorder or established organic impairment (e.g., TBI).
  • Active suicidal risk, self-mutilation or homicidal behavior toward others within the past 3 months, as judged by the PI.
  • Previous ARC treatment.
  • Any other condition that might interfere with the person's capacity to give informed consent, or to adhere to the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Trauma Center at JRI

Brookline, Massachusetts, 02446, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Mental CompetencyTherapeutics

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

JurisprudenceSocial Control, FormalHealth Care Economics and Organizations

Study Officials

  • Hilary B Hodgdon, Ph.D.

    Trauma Center at JRI

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The Attachment, Regulation and Competency (ARC) Framework is an attachment focused model designed specifically for trauma-impacted children that incorporates principles of the following theoretical orientations: 1) developmental theory; 2) family systems theory; and 3) strengths-based approaches. The central goals of the ARC framework are to (a) support caregiving systems and enhance caregiver-child relationships ("Attachment"), (b) support children in developing the skills and tolerance for connecting to, identifying, and sharing internal experience and managing emotional and physiological states ("Regulation"), (c) build key capacities associated with resilience including the ability to engage in problem-solving and a positive / effective sense of self ("Competency"), and (d) process traumatic experiences.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2017

First Posted

December 13, 2021

Study Start

September 1, 2016

Primary Completion

March 31, 2021

Study Completion

March 31, 2021

Last Updated

December 13, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

At this time IPD will not be shared with other researchers.

Locations